A new 4-in-1 weight loss drug could soon replace invasive surgeries like gastric bypass—offering up to 30% body weight loss without going under the knife. Developed by researchers at Tufts University, this breakthrough treatment combines the effects of Mounjaro and Ozempic and goes even further by targeting four powerful hormone receptors, including peptide YY—which may help burn fat directly, not just curb your appetite.
While the drug hasn’t entered human trials yet, experts say it could take several years to be approved. But if it works, this could be one of the biggest revolutions in obesity treatment ever seen.
WooGlobe Ref : WGA485059
For licensing and to use this video, please email licensing@wooglobe.com
